FY2023 Global Cancer Advancements in Immunotherapy Research See how CRI is transforming the lives of cancer patients on a global scale. Watch Highlights Video Want to learn more? We invite you to download the following educational resources. Get the Infographic Explore in-depth insights, at a glance. Download PDF Get the Impact Report Access FY2023 highlights and accomplishments. Download PDF $515M invested in CRI scientists worldwide since 1953 $28.7M invested in research grants and fellowships in FY2023 12 new FDA approvals 01 / Impact Fueling the Next Wave of Discovery CRI funds scientists from around the world to advance new avenues of discovery, new technologies, and new ways to analyze and share data about our immune system and it’s power to outsmart cancer. Watch Impact Video 02 / Cancers Redefining Immunotherapy Success CRI scientists are accelerating discovery thanks to new technologies that marry data science, bioinformatics, and cancer immunology. To date, there are 4M patients eligible for immunotherapy treatments worldwide. Watch Cancers Video 28 cancers now treatable with immunotherapy thanks to the work of CRI Make your impact on cancer research DONATE NOW 03 / people Empowering the Best Scientists CRI’s research is guided by our prestigious Scientific Advisory Council, led by 2018 Nobel Laureate James P. Allison, PhD. Our scientists are leading the charge to advance immunotherapy discovery and shaping the future of the field. Watch People Video 04 / Research Recognizing Research Excellence CRI-funded scientists had 300 publications of news-worthy research in top-tier peer-reviewed academic journals this year. Watch Research Video 300 publications Make your impact on cancer research DONATE NOW 05 / Discovery Unleashing Science with the Power of Data CRI funded a clinical trial spearheaded by Dr. Valsamo “Elsa” Anagnostou, MD, PhD, from Johns Hopkins, investigating ctDNA technology’s potential. This method, through a blood draw, provides valuable insights into tumor genetics and activity. The trial showed that ctDNA analysis yielded faster, more accurate responses and enhanced predictions for long-term patient outcomes. Watch Discovery Video Our Mission Save more lives by fueling the discovery and development of powerful immunotherapies for all cancers. This year, CRI proudly celebrates funding 70 years of discovery in cancer immunotherapy. As a top-tier nonprofit that upholds fiscal integrity and transparency, CRI ensures every donation fuels impactful cancer immunotherapy research. Ranked among the top 5% of U.S. charities, we’re dedicated to saving lives worldwide. Donate Now
